This discussion contains forward-looking statements that are based on current
expectations, estimates, assumptions, and projections about our industry,
business, and future financial results. Our actual results and the timing of
events may differ materially from those described in or implied by these
forward-looking statements due to a number of factors, including those discussed
below and those set forth under "Risk Factors" herein and other filings we make
with the SEC from time to time. Unless the context otherwise requires,
references in this "Management's Discussion and Analysis of Financial Condition
and Results of Operations" to "we," "our," "us," and "AEye," refer to the
business and operations of AEye, Inc.

Overview



We are a provider of high-performance, active lidar system technology for
vehicle autonomy, advanced driver-assistance systems, or ADAS, and robotic
vision applications. With a sophisticated workforce of leaders and researchers,
we have developed an artificial intelligence technology that enables adaptive
"intelligent sensing," differentiating us in the marketplace from our
competition. Our proprietary software-definable 4SightTM Intelligent Sensing
Platform combines solid-state active lidar, an optionally fused low-light HD
camera, and integrated deterministic artificial intelligence to capture more
intelligent information with less data, enabling faster, more accurate, and more
reliable perception of the surroundings.

We were founded in 2013 by Luis Dussan, our Chief Technology Officer, to create
a deterministic AI-driven sensing system that performs better than the human eye
and visual cortex. Mr. Dussan's experience developing mission-critical targeting
systems for fighter jets and ground troops on behalf of the U.S. military
provided him with the background to develop a differentiated approach to visual
sensing. While traditional sensing systems passively collect data, our active
4SightTM Intelligent Sensing Platform leverages principles from automated
targeting systems and biomimicry to scan the environment, while intelligently
focusing on what matters in order to enable safer, smarter, and faster decisions
in complex scenarios. From our inception, our culture has drawn from esteemed
scientists and electro-optics engineers from the National Aeronautics and Space
Administration, or NASA, Lockheed Martin Corporation, Northrop Grumman
Corporation, the U.S. Air Force, and the Defense Advanced Research Projects
Agency, or DARPA, to create the highest performing sensing and perception system
for the most challenging situations, ensuring the highest levels of safety for
autonomous driving.

As a result, our adaptive lidar is designed to enable higher levels of autonomy
and functionality - SAE Levels 2 through 5 - with the goal of optimizing
performance and power, and reducing cost. Our 4Sight™ Intelligent Sensing
Platform is software-definable and network-optimized, and leverages
deterministic artificial intelligence at the edge. We have made substantial
investments in our R&D processes and deliver value to our customers through a
combination of sales and direct channels. We perform the majority of our R&D
activities in our 56,549 square foot corporate headquarters in Dublin,
California. Our modular design facilitates product hardware updates as
technologies evolve, and its small size and modest heat generation enable very
flexible placement options on the interior or exterior of a vehicle. Our 4Sight™
Intelligent Sensing Platform also leverages a common architecture to create
application-specific products across the Automotive, Mobility, and Industrial
markets.

Our systems-based approach encourages partnership from the well-established
automotive supply chain, including original equipment manufacturers, or OEMs, as
well as Tier 1 and Tier 2 suppliers. There is strong alignment between us and
our partners given what is required to produce a high-performance
automotive-grade product at scale, including quality, reliability, and
affordability. Our Tier 1 partners will add value with OEM customers through
industrialization, manufacturing, integration, sales, marketing, product
liability, and warranty. Our Tier 2 partners will provide automotive-grade
sub-components, which are used not only in automotive lidar for ADAS use cases,
but also for our products to be sold in the Industrial and Mobility markets. We
expect the result will be a high-quality, high-performance product at a low
cost, which we believe to be a key enabler in accelerating adoption of lidar
across various markets, including the Automotive market and beyond.

In pursuing this strategy, we have partnered with leading Tier 1 automotive
suppliers including Continental AG, HELLA GmbH & Co. KGaA, Aisin Corporation,
and ZKW Group GmbH (an affiliate of LG Electronics Inc.). One of our Tier 1
partners is currently in the process of bidding for long range lidar series
production awards with OEMs that are expected to represent a substantial portion
of our 2026 forecasted revenues. The main markets for lidar, including
Automotive, Industrial, and Mobility, are projected to see significant growth in
both the near and long term. We believe this expected growth will allow us to
achieve greater market share as well as pursue specialization opportunities like
highway autonomous driving applications that benefit from our products. We
expect that lidar will be a required sensing solution across many end markets,
and we intend to be the leading solutions
                                       31
--------------------------------------------------------------------------------

provider in these spaces.

All dollar amounts expressed in this Management's Discussion and Analysis of Financial Condition and Results of Operations are in thousands of dollars, except for per share amounts and unless otherwise specified.

Business Combination and Public Company Costs



As a result of the Business Combination, which closed on August 16, 2021, a
subsidiary of CF Finance Acquisition Corp III, or CF III, Meliora Merger Sub,
Inc., merged with and into AEye, Inc., then known as AEye Technologies, Inc., or
AEye Technologies, with AEye Technologies continuing as the surviving entity as
a wholly owned subsidiary of CF III, and CF III thereafter operating under the
new name AEye, Inc., or AEye, or the combined entity.

The Business Combination was accounted for as a reverse recapitalization, in
accordance with U.S. GAAP. Under this method of accounting, AEye Technologies
was treated as the accounting acquirer, meaning CF III was treated as the
acquired company for financial reporting purposes. This determination is
primarily based on AEye Technologies' stockholders comprising a majority of the
voting power of the combined entity and having the ability to nominate the
majority of the governing body of the combined entity. Additionally, AEye
Technologies' senior management comprises the senior management of the combined
entity, and AEye Technologies' operations comprise the ongoing operations of the
combined entity. Accordingly, for accounting purposes, the financial statements
of the combined entity will represent a continuation of the financial statements
of AEye Technologies, and the Business Combination will be treated as the
equivalent of AEye Technologies issuing stock for the net assets of CF III,
accompanied by a recapitalization. The most significant change in AEye
Technologies' financial position and results of the business combination was an
increase in cash of $256,811, before transaction costs. Total non-recurring
transaction costs incurred for this transaction were $52,661.

Upon the closing of the Business Combination, our common stock and warrants
began trading under the symbols "LIDR" and "LIDRW," respectively, on the Nasdaq
Stock Market LLC, or Nasdaq. We anticipate that we will continue to hire
additional personnel and implement procedures and processes to address public
company regulatory requirements and customary practices. We have incurred and
expect to incur additional annual expenses as a public company for, among other
things, directors' and officers' liability insurance, director fees, and
additional internal and external accounting and legal and administrative
resources, including increased audit and legal fees.

COVID-19 Impact



The extensive impact of the pandemic caused by the COVID-19 pandemic has
resulted and will likely continue to result in significant disruptions to the
global economy, as well as businesses and capital markets around the world,
despite the reports of declines in severity. The continued impact of the
COVID-19 pandemic on our operational and financial performance will depend on
various future developments, including the duration and spread of the outbreak
and impact on our customers, suppliers, and employees, all of which is uncertain
at this time. We expect the COVID-19 pandemic may adversely impact our future
revenue and results of operations, but we are unable to predict at this time the
size and duration of this adverse impact. For more information on our operations
and risks related to epidemics, including COVID-19, please see the section of
this Quarterly Report on Form 10-Q entitled "Risk Factors."

Key Factors Affecting Our Operating Results



We believe that our future performance and success depends to a substantial
extent on our ability to capitalize on the following opportunities, which in
turn is subject to significant risks and challenges, including those discussed
below, and the risk factors described in the section of this Quarterly Report on
Form 10-Q entitled "Risk Factors."

We are subject to those risks common in the technology industry and also those
risks common to early stage companies including, but not limited to, the
possibility of not being able to successfully develop or commercialize our
products; attract new customers and retain our existing customers; develop and
protect our intellectual property; comply with existing and new or modified laws
and regulations applicable to our business; maintain and enhance the value of
our reputation and brand; hire, integrate, and retain talented people at all
levels of our organization; and successfully develop new solutions to enhance
the experience of, and deliver value to, our customers.

                                       32
--------------------------------------------------------------------------------

Market Trends and Uncertainties



We anticipate growing demand for our 4SightTM Intelligent Sensing Platform
across three major markets - Automotive, Industrial, and Mobility. We also
anticipate that the total addressable market for lidar-based perception
technology will grow to $42 billion by 2030. Within those markets, we are
targeting attractive segments, including advanced driver-assistance systems, or
ADAS, autonomous driving, commercial trucking, robo-taxis, and various
Industrial and Mobility market segments such as mining, aerospace, defense,
shuttles, railway, and intelligent transportation systems, or ITS. This provides
us with multiple opportunities for sustained growth by enabling new applications
and product features across these market segments. However, as our customers
continue R&D projects to commercialize solutions that rely on lidar technology,
it is difficult to estimate the timing of ultimate end market and customer
adoption. In the Automotive market for example, which accounted for 49% and 64%
of our revenue in the nine months ended September 30, 2022 and 2021,
respectively, our growth and financial performance will be heavily influenced by
our ability to successfully integrate into OEM programs that require years of
development, testing, and validation. Because of the size and complexity of
these OEM programs, we see our existing Tier 1 partnerships as a substantial
competitive advantage given their large scale, mass-production capabilities, and
existing OEM customer relationships. Our primary focus in the Automotive market
is on ADAS for passenger and commercial vehicle autonomy, particularly highway
autonomy applications. We believe that growth in that market is driven by both
more stringent safety regulations and consumer demand for vehicles offering
increased safety. We will need to anticipate and adapt to any changes in the
regulatory environment, as well as changes in consumer demand in order to take
advantage of this opportunity.

Additionally, we are increasing our investments in international operations and
partnerships that will position us to expand our business globally and meet
growing demand in international markets. This is an important part of our core
strategy and may expose us to additional factors such as foreign currency risk,
additional operating costs, and other risks and challenges that may impact the
ability to meet projected sales and margin targets.

Partnerships and Commercialization



Our technology is designed to be a key enabler of autonomous solutions for
Automotive, Industrial, and Mobility market applications. Because our technology
must be integrated into a broader solution by our customers, it is critical that
we achieve design wins with these customers. The timing of these design wins
varies based on the market and application. Achieving a design win with an OEM
within the Automotive market may take considerably longer than a design win with
customers in the Industrial or Mobility markets. We consider design wins to be
critical to our future success, although the revenue generated by each design
win and the time necessary to achieve such a win can vary significantly, making
it difficult to predict our financial performance.

We believe our revenue and profitability will also be dependent upon our success
in licensing our technology to Tier 1 automotive suppliers, such as Continental,
which represented 49% and 11% of our revenue in the nine months ended September
30, 2022 and 2021, respectively, that intend to use our technology in volume
production of lidar sensors for OEMs. Delays of autonomy programs by OEMs that
we are currently or will be working with through our Tier 1 partners could
result in us being unable to achieve our revenue and profitability targets in
the timeframe we anticipate. Our overall revenue and profitability will also be
dependent upon both our success in selling our lidar solutions to customers in
the Industrial and Mobility markets.

Gross Margin Improvement



Our gross margins will depend on numerous factors, including, among others, the
selling price of our products, pricing of our development contracts with
customers, royalty rates on licenses we grant to our customers, unit volumes,
product mix, component costs, personnel costs, contract manufacturing costs,
overhead costs, and product features. In the future, we expect to generate
attractive gross margins from licensing our lidar technology and software to our
Tier 1 partners in the Automotive market. We also sell our own lidar solutions
to customers in the Industrial and Mobility markets utilizing low-cost
components that are sourced in part from the Tier 2 automotive supply chain and
assembled by our contract manufacturing partners. If our Tier 1 partners in the
Automotive market do not achieve the volumes that we expect, then the cost of
the components we use to address the Industrial and Mobility markets may be
higher than we currently anticipate and may impact our gross margins and our
ability to achieve profitability.

To date, our revenue has been generated through development contracts with OEMs
and Tier 1 suppliers, as well as unit sales of our products. These development
contracts primarily focus on customization of our proprietary 4Sight
capabilities to our customers' applications, typically involving software
implementation to assist with sensor connection and control, customization of
scan patterns, and enhancement of particular perception capabilities to
                                       33
--------------------------------------------------------------------------------

meet specific customer needs. In general, development contracts that require
more complex configurations have higher prices. We expect development contracts
to represent a smaller share of our total revenue over time, as we increase our
focus on technology licensing and product sales. We expect our gross margins
from the sale of products to improve over time as we outsource volume production
of our lidar sensors to contract manufacturers, which we anticipate will both
increase unit volumes and reduce the cost per unit. In September 2021, we
commenced our transition process to contract manufacturers, and we expect the
first phase of this transition to be complete in late 2022.

Investment and Innovation



Our proprietary adaptive, intelligent lidar technology delivers industry-leading
performance that helps to solve the most difficult challenges in delivering
partial or full autonomy. While traditional sensing systems passively collect
data, our active 4Sight™ Intelligent Sensing Platform leverages principles from
automated targeting systems and biomimicry to scan the environment, while
intelligently focusing on what matters most in order to enable safer, smarter,
and faster decisions in complex scenarios.

We believe our financial performance is significantly dependent on our ability
to maintain a technology leadership position. This is further dependent on the
investments we make in R&D. It is essential that we continually identify and
respond to rapidly evolving customer requirements, develop and introduce
innovative new products, enhance and service existing products, and generate
strong market demand for our products. If we fail to do this, our leading market
position and revenue may be adversely affected, and our investments in that area
will not be recovered.

Basis of Presentation

We currently conduct our business through one operating segment.

Components of Results of Operations

Total Revenues



We categorize our revenue as (1) prototype sales and (2) development contracts.
In 2022 and 2021, our prototype sales revenue primarily related to unit sales of
the company's 4Sight M product. Revenue from prototype sales is typically
recognized at a point in time when the control of goods is transferred to the
customer, generally upon delivery or shipment to the customer.

Development contracts represented the majority of our total revenues in 2021 and
the first three quarters of 2022. Revenue from development contracts are earned
from R&D activities and collaboration with OEMs and Tier 1 suppliers. These
contracts primarily focus on customization of our proprietary 4Sight
capabilities to our customers' applications, typically involving software
implementation to assist with sensor connection and control, customization of
scan patterns, and enhancement of perception capabilities to meet specific
customer needs. Revenue from development contracts is recognized when we satisfy
performance obligations in the contract, which can result in recognition at
either a point in time or over time. This assessment is made at the outset of
the arrangement for each performance obligation.

Cost of Revenue



Cost of revenue includes the costs directly associated with the production of
prototypes and certain costs associated with development contracts. Such costs
for prototypes include direct materials, direct labor, indirect labor, inventory
write-downs, warranty expense, and allocation of overhead. Costs associated with
development contracts include the direct costs and allocation of overhead costs
involved in the execution of the contracts.

Operating Expenses

Research and Development



Our research and development, or R&D, efforts are focused primarily on hardware,
software, and system engineering related to the design and development of our
advanced lidar solutions. R&D expenses include:

•personnel-related expenses, including salaries, benefits, bonuses, and stock-based compensation expense;


                                       34
--------------------------------------------------------------------------------

•third-party engineering and contractor costs;
•lab equipment;
•new hardware and software expenses; and
•allocated overhead expenses.

R&D costs are expensed as they are incurred. We expect our investment in R&D
will continue to grow over time because we believe that investment in R&D is
essential to maintain our position as a provider of one of the most advanced
lidar solutions available.

Sales and Marketing

Our sales and marketing, or S&M, efforts are focused primarily on sales, business development, and marketing programs in pursuit of revenue contracts from potential and existing customers. S&M expenses include:



•personnel-related expenses, including salaries, benefits, bonuses, and
stock-based compensation expense;
•demonstration equipment;
•trade shows expenses, advertising, and promotions expenses for press releases
and other public relations services; and
•allocated overhead expenses.

We expect our S&M expenses to grow over time as we continue to expand our sales and marketing efforts to support the anticipated growth of our business.

General and Administrative

Our general and administrative, or G&A, spending supports all business functions. G&A expenses include:



•personnel-related costs, including salaries, benefits, bonuses, and stock-based
compensation for executive, finance, legal, human resources, technical support,
and other administrative personnel;
•consulting, accounting, legal, and other professional fees;
•insurance premiums, software and computer equipment costs, general office
expenses; and
•allocated overhead expenses.

We expect our G&A expenses to increase for the foreseeable future as we increase
our headcount to support the growth of our business, and as a result of
operating as a public company, including additional costs and expenses
associated with compliance with the rules and regulations of the SEC, as well as
legal, audit, insurance, investor relations, and other administrative and
professional services.

Change in Fair Value of Warrant Liabilities



Change in fair value of warrants are non-cash changes and primarily consists of
changes in fair value related to the warrant liabilities. The warrant
liabilities are classified as marked-to-market liabilities pursuant to ASC 480,
and the corresponding increase or decrease in value impacts our net loss.

Interest Income, Interest Expense and Other



Interest income consists primarily of interest earned on our cash, cash
equivalents, and marketable securities. These amounts will vary based on our
cash and cash equivalents balances and market rates. Interest expense consists
primarily of convertible note issuance costs and amortization of premiums on
marketable securities, net of accretion of discounts.

Upon the closing of the Business Combination, our borrowings were repaid with
any remaining debt issuance costs and discounts expensed. The pre-Business
Combination convertible notes and accrued interest were settled and converted to
Class A common stock. See additional discussion in Note 2 to our condensed
consolidated financial statements.

                                       35
--------------------------------------------------------------------------------

Results of Operations

Comparison of the Three Months Ended September 30, 2022 and 2021



The results of operations presented below should be reviewed in conjunction with
the consolidated financial statements and notes included elsewhere in this
report. The following table sets forth our consolidated results of operations
data for the three months ended September 30, 2022 and 2021 (in thousands,
except for percentages):

                                          Three Months Ended September 30,              Change                 Change
                                              2022                   2021                  $                     %
Prototype sales                       $             652          $      127          $      525                      413  %
Development contracts                               115                   -                 115                      100  %
Total revenues                                      767                 127                 640                      504  %
Cost of revenue                                   2,708                 466               2,242                      481  %
Gross (loss) profit                              (1,941)               (339)             (1,602)                     473  %
Research and development                          8,971               7,468               1,503                       20  %
Sales and marketing                               4,466               2,991               1,475                       49  %
General and administrative                        7,896               6,086               1,810                       30  %
Total operating expenses                         21,333              16,545               4,788                       29  %
Loss from operations                            (23,274)            (16,884)             (6,390)                      38  %
Change in fair value of embedded
derivative and warrant liabilities                   16                 341                (325)                     (95) %

Interest income and other                           335                  69                 266                      386  %
Interest expense and other                         (688)               (919)                231                      (25) %
Total other income (expense), net                  (337)               (509)                172                      (34) %
Provision for income tax expense                     13                   -                  13                      100  %
Net loss                              $         (23,624)         $  (17,393)         $   (6,231)                      36  %



Revenue

Prototype Sales

Prototype sales revenue increased by $525, or 413%, to $652 for the three months
ended September 30, 2022, from $127 for the three months ended September 30,
2021. This increase was primarily due to an increase in 4Sight M unit sales.

Development Contracts



Development contracts revenue increased by $115 to $115 for the three months
ended September 30, 2022, from $0 for the three months ended September 30, 2021.
The increase was primarily due to revenue recognized in the current year from a
large Tier 1 Automotive Supplier contract.

Cost of Revenue



Cost of revenue increased by $2,242, or 481%, to $2,708 for the three months
ended September 30, 2022, from $466 for the three months ended September 30,
2021. This increase was primarily due to the cost of revenue associated with the
Tier 1 automotive supplier contract in the current period and increased
prototype sales as well as increased labor and warranty costs.

                                       36
--------------------------------------------------------------------------------

Operating Expenses

Research and Development



Research and development expenses increased by $1,503, or 20%, to $8,971 for the
three months ended September 30, 2022, from $7,468 for the three months ended
September 30, 2021. This increase was primarily driven by increases in
stock-based compensation expense of $1,234, personnel costs of $680, rent and
facilities expense of $321, and travel expense of $112. The above mentioned
increases were offset by a decrease in third party research and development work
and engineering parts of $1,027.

Sales and Marketing



Total sales and marketing expenses increased by $1,475, or 49%, to $4,466 for
the three months ended September 30, 2022, from $2,991 for the three months
ended September 30, 2021. This increase was primarily due to stock-based
compensation expense of $841, travel expense of $174, marketing program spend of
$161, information technology expense of $109, and marketing consultant spend of
$96.

General and Administrative

Total general and administrative expenses increased by $1,810, or 30%, to $7,896
for the three months ended September 30, 2022, from $6,086 for the three months
ended September 30, 2021. This increase was primarily due to an increase in
stock-based compensation expense of $1,696, professional accounting and legal
fees of $526, and directors' and officers' insurance of $397. These increases
were partially offset by a decrease in personnel costs of $756 due to lower
accrued payroll.

Change in Fair Value of Embedded Derivative and Warrant Liabilities



Change in fair value of embedded derivative and warrant liabilities decreased by
$325, or 95%, to a gain of $16 for the three months ended September 30, 2022,
from a gain of $341 for the three months ended September 30, 2021. This decrease
was primarily due to a decrease in the fair value of the private warrant
liabilities in the current period compared to prior period warrant liability.

Interest Income and Other

Interest income and other increased by $266, or 386%, to $335 for the three months ended September 30, 2022, from $69 for the three months ended September 30, 2021. This increase was primarily due to the interest earned on our marketable securities.

Interest Expense and Other



Interest expense and other decreased by $231, or 25%, to $688 for the three
months ended September 30, 2022, from $919 for the three months ended September
30, 2021. This decrease was primarily due to $866 of prior period interest
expense not recurring in the current year due to the payoff of the loan balances
in the prior year. This is offset by increases of $150 in amortization of
premiums on marketable securities, net of accretion of discounts, and $381 of
convertible note issuance costs in the current period.

Provision for Income Tax Expense



Provision for income tax expenses increased to $13 for the three months ended
September 30, 2022, from $0 for the three months ended September 30, 2021. This
increase is due to changes in pretax income (loss) in the U.S. and certain
foreign entities and changes in tax rates.

Net Loss

Net loss increased by $6,231, or 36%, to $23,624 for the three months ended September 30, 2022, from $17,393 for the three months ended September 30, 2021. This increase was primarily due to an increase in operating expenses.


                                       37
--------------------------------------------------------------------------------

Comparison of the Nine Months Ended September 30, 2022 and 2021



The results of operations presented below should be reviewed in conjunction with
the consolidated financial statements and notes included elsewhere in this
report. The following table sets forth our consolidated results of operations
data for the nine months ended September 30, 2022 and 2021 (in thousands, except
for percentages):

                                              Nine Months Ended
                                                September 30,                     Change                 Change
                                           2022                2021                  $                      %
Prototype sales                       $     1,182          $      588          $      594                       101  %
Development contracts                       1,373                 615                 758                       123  %
Total revenues                              2,555               1,203               1,352                       112  %
Cost of revenue                             5,617               1,537               4,080                       265  %
Gross (loss) profit                        (3,062)               (334)             (2,728)                      817  %
Research and development                   28,309              19,030               9,279                        49  %
Sales and marketing                        14,405               6,489               7,916                       122  %
General and administrative                 29,053              13,846              15,207                       110  %
Total operating expenses                   71,767              39,365              32,402                        82  %
Loss from operations                      (74,829)            (39,699)            (35,130)                       88  %
Change in fair value of embedded
derivative and warrant liabilities            125                 222                 (97)                      (44) %
Gain on PPP loan forgiveness                    -               2,297              (2,297)                     (100) %
Interest income and other                   1,109                  74               1,035                     1,399  %
Interest expense and other                 (1,338)             (2,871)              1,533                       (53) %
Total other income (expense), net            (104)               (278)                174                       (63) %
Provision for income tax expense               39                   -                  39                       100  %
Net loss                              $   (74,972)         $  (39,977)         $  (34,995)                       88  %



Revenue

Prototype Sales

Prototype sales revenue increased by $594, or 101%, to $1,182 for the nine months ended September 30, 2022, from $588 for the nine months ended September 30, 2021. This increase was primarily due to an increase in 4Sight M unit sales.

Development Contracts



Development contracts revenue increased by $758, or 123%, to $1,373 for the nine
months ended September 30, 2022, from $615 for the nine months ended September
30, 2021. The increase was primarily due to revenue recognized in the current
year from a Tier 1 automotive supplier development contract.

Cost of Revenue



Cost of revenue increased by $4,080, or 265%, to $5,617 for the nine months
ended September 30, 2022, from $1,537 for the nine months ended September 30,
2021. This increase was primarily due to the increase in prototype sales and the
cost of revenue associated with the Tier 1 automotive supplier development
contract.

                                       38
--------------------------------------------------------------------------------

Operating Expenses

Research and Development



Research and development expenses increased by $9,279, or 49%, to $28,309 for
the nine months ended September 30, 2022, from $19,030 for the nine months ended
September 30, 2021. This increase was primarily driven by increases in personnel
costs of $5,125, stock-based compensation expense of $3,105, rent and facilities
expense of $653 information technology expense of $636, and travel expense of
$305, partially offset by a decrease in third party research and development
work and engineering parts of $868.

Sales and Marketing



Total sales and marketing expenses increased by $7,916, or 122%, to $14,405 for
the nine months ended September 30, 2022, from $6,489 for the nine months ended
September 30, 2021. This increase was primarily due to increases in personnel
costs of $2,877, stock-based compensation expense of $2,306, marketing program
spend of $1,096, travel expense of $707, information technology expense of $310,
consultant expense of $239, and rent and facilities expense of $223.

General and Administrative



Total general and administrative expenses increased by $15,207, or 110%, to
$29,053 for the nine months ended September 30, 2022, from $13,846 for the nine
months ended September 30, 2021. This increase was primarily due to increases in
stock-based compensation expense of $5,984, professional accounting and legal
fees of $3,835, directors' and officers' insurance of $2,923, personnel costs of
$1,694, and investor agency and stock-related expenses of $589, and travel
expense of $345. These increases were partially offset by decreases in
information technology expense of $194.

Change in Fair Value of Embedded Derivative and Warrant Liabilities



Change in fair value of embedded derivative and warrant liabilities decreased by
$97, or 44%, to a gain of $125 for the nine months ended September 30, 2022,
from a gain of $222 for the nine months ended September 30, 2021. This decrease
was primarily due to a decrease in the fair value of the private warrant
liabilities in the current period compared to the prior period.

Gain on PPP Loan Forgiveness



Gain on PPP loan forgiveness decreased by $2,297 to $0 for the nine months ended
September 30, 2022, from $2,297 for the nine months ended September 30, 2021. In
June 2021, the full principal and interest of the PPP loan was forgiven.

Interest Income and Other

Interest income and other increased by $1,035 to $1,109 for the nine months ended September 30, 2022, from $74 for the nine months ended September 30, 2021. This increase was primarily due to the interest earned on our marketable securities.

Interest Expense and Other



Interest expense and other decreased by $1,533, or 53%, to $1,338 for the nine
months ended September 30, 2022, from $2,871 for the nine months ended September
30, 2021. This decrease was primarily due to $2,818 of prior period interest
expense not recurring in the current year due to the payoff of the loan balances
in the prior year. This is offset by increases of $758 in amortization of
premiums on marketable securities, net of accretion of discounts, and $381 of
convertible note issuance costs in the current period.

Provision for Income Tax Expense



Provision for income tax expenses increased to $39 for the nine months ended
September 30, 2022, from $0 for the nine months ended September 30, 2021. This
increase is primarily due to changes in pretax income (loss) in the U.S. and
certain foreign entities and changes in tax rates.

                                       39
--------------------------------------------------------------------------------

Net Loss

Net loss increased by $34,995, or 88%, to $74,972 for the nine months ended September 30, 2022, from $39,977 for the nine months ended September 30, 2021. This increase was primarily due to an increase in operating expenses.

Liquidity and Capital Resources

Sources of Liquidity



Our capital requirements will depend on many factors, including sales volume,
the timing and extent of spending to support R&D efforts, investments in
information technology systems, the expansion of sales and marketing activities,
increased costs as we continue to hire additional personnel, and market adoption
of new and enhanced products and features. As of September 30, 2022, our cash,
cash equivalents, and marketable securities totaled $112.2 million.

To date, our principal sources of liquidity have been proceeds received from the
issuance of equity. In December 2021, we entered into a Common Stock Purchase
Agreement, or CSPA, with Tumim Stone Capital LLC, or Tumim Stone, pursuant to
which we have the right, but not the obligation, to issue and sell to Tumim
Stone, over a 36-month period, up to $125,000 of the Company's common stock. On
May 6, 2022, the Company filed a Registration Statement on Form S-1, which
related to the offer and resale of up to 30,865,419 shares of our common stock
to be purchased by Tumim Stone, pursuant to the CSPA. As of September 30, 2022,
1,145,000 shares were issued under this CSPA. In September 2022, we entered into
a Securities Purchase Agreement ("SPA") with an investor allowing for the sale
and issuance of two convertible notes, each with cash proceeds of $10,000, for a
total of $20,000 in proceeds between the two issuances (each, a "Note Closing").
On September 15, 2022, we closed the first Note Closing with the investor and
received cash proceeds of $10,000. The second Note Closing may occur, at our
option, after the ninetieth (90th) calendar day after the first Note Closing and
provided that we meet certain equity conditions. Until we can generate
sufficient revenue from the sale of our products to cover operating expenses,
working capital, and capital expenditures, we expect the funds raised in the
Business Combination and PIPE financing, as well as any future funds from the
CSPA and SPA, and other potential sources of capital, to fund our near-term cash
needs.

If we are required to raise additional funds by issuing equity securities,
dilution of stockholders will result. Any debt securities issued may also have
rights, preferences, and privileges senior to those of holders of our common
stock. The terms of debt securities or borrowings could impose significant
restrictions on our operations. The credit market and financial services
industry have in the past, and may in the future, experience periods of
uncertainty that could impact the availability and cost of equity and debt
financing.

For the nine months ended September 30, 2022 and 2021, we had a net loss of
$74,972 and $39,977, respectively. We anticipate that we will continue to incur
losses for at least the next several years. We expect that our research and
development, selling and marketing, and general and administrative expenses will
continue to be significant and, as a result, we may need additional capital
resources to fund our operations. We believe that the net proceeds from the
Business Combination and CSPA, together with our existing cash, cash
equivalents, and marketable securities, will enable us to fund our operating
expenses, working capital, and capital expenditure requirements for a period of
at least twelve months from September 30, 2022. Our plans for the use of cash in
the long-term (beyond the twelve months indicated above) are similarly related
to funding operating expenses, working capital, and capital expenditure
requirements as we continue to scale the business. For additional information
regarding our cash requirements from lease obligations and contractual
obligations, see Notes 7 and 19 to the Condensed Consolidated Financial
Statements in Item 1 of Part I of this Quarterly Report on Form 10-Q.

                                       40
--------------------------------------------------------------------------------


Cash Flow Summary

                                           Nine months ended September 30,
                                                 2022                     2021
                                                    (in thousands)
Net cash provided by (used in):
Operating activities                $        (55,525)                 $  (39,588)
Investing activities                $         90,190                  $ (130,712)
Financing activities                $          9,642                  $  208,421



Operating Activities

For the nine months ended September 30, 2022, net cash used in operating
activities was $55,525. Factors affecting our operating cash flows during this
period were a net loss of $74,972, offset by stock-based compensation of
$18,003, depreciation and amortization of $794, inventory write-downs of $576,
and amortization of premiums on marketable securities, net of changes in accrued
interest, of $1,211. Within operating activities, the net changes in operating
assets and liabilities were cash used of $2,082, primarily driven by increases
in inventories and prepaid and other current assets of $2,256 and $445,
respectively, and decreases in accounts payable, contract liabilities, and
operating lease liabilities of $1,236, $1,400, and $983, respectively, offset by
cash provided by decreases in accounts receivable of $3,598 and increases in
accrued expenses and other current liabilities of $220.

For the nine months ended September 30, 2021, net cash used in operating
activities was $39,588. Factors affecting our operating cash flows during this
period were net loss of $39,977 and a gain on PPP loan forgiveness of $2,297,
offset by stock-based compensation of $6,522, depreciation and amortization of
$769, and amortization of debt issuance costs of $725. Within operating
activities net changes in operating assets and liabilities were cash provided of
$6,193, primarily driven by increases in prepaid and other current assets of
$5,305 and inventory of $2,197, partially offset by increases in accrued
expenses and other current liabilities of $1,417, and accounts payable of $840.

Investing Activities



For the nine months ended September 30, 2022, net cash provided by investing
activities was $90,190. The primary factor affecting net cash provided by
investing activities during this period were the proceeds from redemption of
marketable securities of $93,592, offset by purchases of property and equipment
of $3,402.

For the nine months ended September 30, 2021, net cash used in investing
activities was $130,712. The primary factor affecting net cash used in investing
activities during this period was the purchase of available-for-sale securities
of $129,999.

Financing Activities

For the nine months ended September 30, 2022, net cash provided by financing
activities was $9,642. The primary factors affecting our financing cash flows
during this period were proceeds from the issuance of convertible notes of
$10,000 and proceeds from the exercise of the CSPA of $2,891, partially offset
by payments for taxes related to net settlement of equity awards of $4,252.

For the nine months ended September 30, 2021, net cash provided by financing
activities was $208,421. The primary factor affecting our financing cash flows
during this period were the proceeds from the Business Combination and private
offering of $256,811, partially offset by transaction costs related to the
Business Combination of $47,775, proceeds from a bank loan of $10,000, offset by
principal payments on the credit facility of $13,333.

Critical Accounting Policies and Estimates



Our condensed consolidated financial statements are in accordance with U.S.
GAAP. We are required to make estimates and assumptions that affect the reported
amounts of assets and liabilities as of the date of the consolidated financial
statements, the reported amounts of revenues and expenses during the reporting
periods, fair value measures, and the related disclosures in the condensed
consolidated financial statements. Our actual results could differ significantly
from these estimates due to changes in judgments, assumptions, and conditions as
a result
                                       41
--------------------------------------------------------------------------------

of unforeseen events or otherwise, which could have a material impact on our
financial position and results of operations. We believe our critical accounting
policies involve the greatest degree of judgment and complexity and have the
greatest potential impact on our condensed consolidated financial statements.

During the nine months ended September 30, 2022, there were no significant changes in our critical accounting policies and estimates as compared to those previously disclosed in "Critical Accounting Policies and Estimates" in "Management's Discussion and Analysis of Financial Condition and Results of Operations" included in our 2021 Annual Report on Form 10-K.

Emerging Growth Company Status



Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012, or the
JOBS Act, exempts emerging growth companies from being required to comply with
new or revised financial accounting standards until private companies are
required to comply with the new or revised financial accounting standards. The
JOBS Act provides that a company can choose not to take advantage of the
extended transition period and comply with the requirements that apply to
non-emerging growth companies, and any such election to not take advantage of
the extended transition period is irrevocable.

We are an "emerging growth company" as defined in Section 2(a) of the Securities
Act, and we have elected to take advantage of the benefits of the extended
transition period for new or revised financial accounting standards. Following
the closing of the Business Combination, we will remain an emerging growth
company until the earliest of (i) the last day of the fiscal year in which the
market value of common stock that is held by non-affiliates exceeds $700 million
as of the end of that year's second fiscal quarter, (ii) the last day of the
fiscal year in which the Company has total annual gross revenue of $1.07 billion
or more during such fiscal year (as indexed for inflation), (iii) the date on
which the Company has issued more than $1.0 billion in non-convertible debt in
the prior three-year period, or (iv) December 31, 2025. We expect to continue to
take advantage of the benefits of the extended transition period, although we
may decide to adopt such new or revised accounting standards early to the extent
permitted by such standards. This may make it difficult or impossible to compare
our financial results with the financial results of another public company that
is either not an emerging growth company or is an emerging growth company that
has chosen not to take advantage of the extended transition period exemptions
because of the potential differences in accounting standards used.

Recent Accounting Pronouncements

See Note 1 to our financial statements included elsewhere in this Quarterly Report on Form 10-Q for recently adopted accounting pronouncements and recently issued accounting pronouncements not yet adopted as of the date of this Quarterly Report on Form 10-Q.

© Edgar Online, source Glimpses